Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Neurological Biomarkers Market, by Region, 2019-2027 (USD Billion)
1.2.2. Neurological Biomarkers Market, by Application, 2019-2027 (USD Billion)
1.2.3. Neurological Biomarkers Market, by Type, 2019-2027 (USD Billion)
1.2.4. Neurological Biomarkers Market, by End-use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neurological Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neurological Biomarkers Market Dynamics
3.1. Neurological Biomarkers Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of neurological diseases
3.1.1.2. Increasing investment for R&D activities
3.1.2. Market Challenges
3.1.2.1. Lack of consumer awareness
3.1.3. Market Opportunities
3.1.3.1. Development in technology in biomarkers
Chapter 4. Global Neurological Biomarkers Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Neurological Biomarkers Market, by Application
5.1. Market Snapshot
5.2. Global Neurological Biomarkers Market by Application, Performance - Potential Analysis
5.3. Global Neurological Biomarkers Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
5.4. Neurological Biomarkers Market, Sub Segment Analysis
5.4.1. Alzheimer's Disease
5.4.2. Parkinson's Disease
5.4.3. Multiple Sclerosis
5.4.4. Autism Spectrum Disorder
5.4.5. Others
Chapter 6. Global Neurological Biomarkers Market, by Type,
6.1. Market Snapshot
6.2. Global Neurological Biomarkers Market by Type, Performance-Potential Analysis
6.3. Global Neurological Biomarkers Market Estimates & Forecasts by Type, 2018-2027 (USD Billion)
6.4. Neurological Biomarkers Market, Sub Segment Analysis
6.4.1. Genomic
6.4.2. Proteomic
6.4.3. Metabolomic
6.4.4. Imaging
6.4.5. Others
Chapter 7. Global Neurological Biomarkers Market, by End-use,
7.1. Market Snapshot
7.2. Global Neurological Biomarkers Market by End-use, Performance-Potential Analysis
7.3. Global Neurological Biomarkers Market Estimates & Forecasts by End-use, 2018-2027 (USD Billion)
7.4. Neurological Biomarkers Market, Sub Segment Analysis
7.4.1. Hospital & Hospital Laboratories
7.4.2. Independent Clinical Diagnostic Centers
7.4.3. Research Organizations and Others
Chapter 8. Global Neurological Biomarkers Market, Regional Analysis
8.1. Neurological Biomarkers Market, Regional Market Snapshot
8.2. North America Neurological Biomarkers Market
8.2.1. U.S. Neurological Biomarkers Market
8.2.1.1. Application breakdown estimates & forecasts, 2018-2027
8.2.1.2. Type breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-use breakdown estimated & forecasts, 2018-2027
8.2.2. Canada Neurological Biomarkers Market
8.3. Europe Neurological Biomarkers Market Snapshot
8.3.1. U.K. Neurological Biomarkers Market
8.3.2. Germany Neurological Biomarkers Market
8.3.3. France Neurological Biomarkers Market
8.3.4. Spain Neurological Biomarkers Market
8.3.5. Italy Neurological Biomarkers Market
8.3.6. Rest of Europe Neurological Biomarkers Market
8.4. Asia-Pacific Neurological Biomarkers Market Snapshot
8.4.1. China Neurological Biomarkers Market
8.4.2. India Neurological Biomarkers Market
8.4.3. Japan Neurological Biomarkers Market
8.4.4. Australia Neurological Biomarkers Market
8.4.5. South Korea Neurological Biomarkers Market
8.4.6. Rest of Asia Pacific Neurological Biomarkers Market
8.5. Latin America Neurological Biomarkers Market Snapshot
8.5.1. Brazil Neurological Biomarkers Market
8.5.2. Mexico Neurological Biomarkers Market
8.6. Rest of The World Neurological Biomarkers Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Application Summary
9.2.1.5. Recent Developments
9.2.2. Thermo Fisher Scientific, Inc.
9.2.3. Bio-Rad Laboratories, Inc.
9.2.4. Merck & Co., Inc.
9.2.5. Johnson & Johnson Services, Inc.
9.2.6. Banyan Biomarkers, Inc.
9.2.7. Myriad Genetics, Inc.
9.2.8. DiaGenic ASA
9.2.9. Quanterix
9.2.10. Myriad RBM
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption